Kazakhstan vs Mauritius: Prevalence rate of obesity in adults
Kazakhstan
21.1%
in 2024
Mauritius
21.1%
in 2024
Kazakhstan rank
113th
Mauritius rank
114th
Prevalence rate of obesity in adults over time
- Kazakhstan
- Mauritius
How they compare
Kazakhstan currently reports 21.1% against 21.1% in Mauritius, a difference of 0.0%.
The two have swapped places 2 times across 45 shared years of data; in 1980 it was Kazakhstan ahead.
Kazakhstan ranks 113th and Mauritius ranks 114th of 199 countries.
Kazakhstan has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Kazakhstan | Mauritius | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 12.3% | 6.5% | 5.8% | Kazakhstan |
| 1990s | 13.1% | 10.2% | 2.9% | Kazakhstan |
| 2000s | 14.5% | 14.2% | 0.3% | Kazakhstan |
| 2010s | 17.3% | 17.3% | 0.0% | Kazakhstan |
| 2020s | 20.3% | 20.1% | 0.1% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of obesity in adults, Kazakhstan or Mauritius?
- Kazakhstan, at 21.1% against 21.1% in Mauritius as of 2024.
- What is the difference in prevalence rate of obesity in adults between Kazakhstan and Mauritius?
- 0.0%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Mauritius?
- 45 years are reported by both, from 1980 to 2024.
- How do Kazakhstan and Mauritius rank globally for prevalence rate of obesity in adults?
- Kazakhstan ranks 113th and Mauritius ranks 114th of 199 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of obesity in adults. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated prevalence of obesity in adults, based on general population surveys and statistical modeling. Obesity is a risk factor for chronic complications, including cardiovascular disease, and premature death.